None listed
Conditions
Interventions
Drug : This study targets patients visiting Hallym University Sacred Heart Hospital who are clinically indicated for brain amyloid PET/CT imaging. Each patient will receive half the standard F-18 FMM
Sponsors
Hallym University Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Male and female adults aged 60 years or older ? Individuals who are able to communicate in Korean and have fully understood and consented to the purpose and procedures of the study ? Patients who, in the investigator’s judgment, possess sufficient vision, hearing, language ability, motor function, and comprehension to follow the study procedures (use of assistive devices such as glasses or hearing aids is permitted) ? Patients with the cognitive ability to make an autonomous decision to participate in the study
Exclusion criteria
Exclusion criteria: ? Cases in which other potential causes of cognitive impairment are suspected based on hematologic tests or brain MRI performed within the past 6 months, including neurosyphilis, hypo/hyperthyroidism, metabolic encephalopathy, brain tumor, acute cerebral hemorrhage, acute cerebral infarction, or Wernicke’s encephalopathy ? Employees directly involved in this clinical study or their immediate family members, if deemed unable to voluntarily participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of the trend and absolute agreement of SUVR values between denoised images and standard images. | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analysis of SUVR values between denoised images and standard images;Comparison of PSNR, SSIM, and NRMSE between denoised images and standard images | — |
Countries
Korea, Republic of
Contacts
Public ContactDongwoo Kim
Hallym University Medical Center
Outcome results
None listed